PDS Biotechnology Corp - Common (PDSB)

Historical Holders from Q1 2019 to Q4 2025

Type / Class
Equity / Common
Symbol
PDSB on Nasdaq
Shares outstanding
49,594,356
Price per share
$0.7698
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
5,620,337
Holdings value
$6,638,921
% of all portfolios
0%
Share change
-1,817,614
Value change
-$1,895,963
Average buys %
+0%
Average sells %
-0%
Number of holders
47
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, PDS Biotechnology Corp - Common (PDSB) has 47 institutional shareholders filing 13F forms. They hold 5,620,337 shares of 49,594,356 outstanding shares (11%) .

Top 25 institutional shareholders own 11% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 3.8% 1,901,441 -2.6% 0% $1,920,455
BlackRock, Inc. 1% 517,519 +0.61% 0% $522,694
GEODE CAPITAL MANAGEMENT, LLC 0.97% 481,999 +15% 0% $486,906
CITADEL ADVISORS LLC 0.78% 386,430 +55% 0% $390,294
INSPIRION WEALTH ADVISORS, LLC 0.69% 344,394 +339% 0.18% $1,315,585
Squarepoint Ops LLC 0.59% 291,627 +198% 0% $294,543
RENAISSANCE TECHNOLOGIES LLC 0.56% 275,861 +161% 0% $278,620
BLAIR WILLIAM & CO/IL 0.5% 250,000 0% 0% $252,500
UBS Group AG 0.4% 200,236 -63% 0% $202,238
STATE STREET CORP 0.27% 133,333 0% 0% $134,666
NORTHERN TRUST CORP 0.23% 113,472 -7.2% 0% $114,607
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.19% 94,344 +604% 0% $95,287
COMMONWEALTH EQUITY SERVICES, LLC 0.18% 90,497 -0.19% 0% $91,000
Iron Gate Global Advisors LLC 0.15% 75,016 0.01% $76,516
ACADIAN ASSET MANAGEMENT LLC 0.12% 61,793 0% $61,000
Watts Gwilliam & Co., LLC 0.11% 55,000 0% 0.01% $55,550
Tempus Wealth Planning, LLC 0.1% 47,800 0% 0.01% $48,278
JANE STREET GROUP, LLC 0.07% 36,581 -47% 0% $36,947
Rockefeller Capital Management L.P. 0.07% 34,467 0% $34,812
Bank of New York Mellon Corp 0.06% 29,293 0% 0% $29,586
XTX Topco Ltd 0.04% 19,699 0% $19,896
Federation des caisses Desjardins du Quebec 0.04% 18,800 0% 0% $18,988
DIMENSIONAL FUND ADVISORS LP 0.04% 18,382 0% 0% $18,566
FIRST MANHATTAN CO. LLC. 0.03% 15,000 0% 0% $15,150
TWO SIGMA SECURITIES, LLC 0.03% 14,149 -37% 0% $14,290

Institutional Holders of PDS Biotechnology Corp - Common (PDSB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 180,495 $138,945 -$126,169 $0.7698 1
2025 Q3 5,620,337 $6,638,921 -$1,895,963 $1.01 47
2025 Q2 7,451,352 $9,901,943 -$1,043,791 $1.33 55
2025 Q1 8,226,452 $9,789,276 +$4,484,826 $1.19 46
2024 Q4 4,234,400 $6,905,609 -$572,438 $1.63 50
2024 Q3 4,325,988 $16,519,540 -$3,544,298 $3.82 57
2024 Q2 5,489,170 $16,082,465 -$6,951,247 $2.93 73
2024 Q1 7,611,671 $30,140,860 -$3,801,963 $3.96 69
2023 Q4 12,037 $59,824 -$82,384 $4.97 1
2023 Q3 7,861,668 $39,699,568 -$456,649 $5.05 78
2023 Q2 7,930,214 $39,888,508 -$209,982 $5.03 79
2023 Q1 7,611,956 $46,811,342 +$1,064,384 $6.15 65
2022 Q4 6,820,799 $90,031,703 +$24,023,999 $13.20 63
2022 Q3 5,151,654 $15,299,000 -$457,844 $2.97 39
2022 Q2 5,251,472 $19,171,000 -$3,835,863 $3.65 46
2022 Q1 5,850,767 $36,215,000 -$1,226,692 $6.19 48
2021 Q4 5,895,951 $47,754,000 -$12,313,755 $8.10 61
2021 Q3 6,752,518 $100,597,635 +$11,330,651 $14.90 58
2021 Q2 5,942,074 $74,432,183 +$36,136,589 $12.55 43
2021 Q1 3,145,587 $14,312,158 +$1,628,141 $4.55 29
2020 Q4 3,028,516 $6,480,955 -$486,817 $2.14 24
2020 Q3 3,193,668 $7,438,573 +$3,519,290 $2.33 25
2020 Q2 1,685,835 $3,388,000 +$618,481 $2.01 16
2020 Q1 1,626,748 $1,183,000 +$802,390 $0.7262 18
2019 Q4 565 $2,000 -$53,193 $3.55 2
2019 Q3 509,321 $1,716,054 +$213,131 $3.37 16
2019 Q2 104 $1,000 -$40,452 $9.62 1
2019 Q1 270,259 $1,999,000 +$1,998,999 $7.40 12